Treatment and Prevention Research for SARS-CoV-2
We are working with researchers around the world on the fight against SARS-CoV-2, with dedicated testing kits and solutions to better study and understand viruses, as well as technology to automate and speed workflows.
For research use only. Not for use in diagnostic procedures.
Explore Our SARS-CoV-2 Testing Solutions for Research
SARS-CoV-2 Nucleic Acid Testing Kit RUO
Streamline your laboratory developed SARS-CoV-2 testing with the PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit (RUO), a PCR assay using fluorescent-labeled probes specific to the 2019 coronavirus (SARS-CoV-2) open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) genes.
Viral RNA Isolation
PerkinElmer chemagen has developed a SARS-CoV-2 RNA isolation kit named chemagic Viral DNA/RNA 300 Kit H96 (cat # CMG-1033-S) for automated isolation from 300 µl of below listed sample materials using the chemagic™ 360 instrument (cat. # 2024-0020) equipped with a chemagic 96 Rod Head Set (cat. # CMG-370).
explorer™ Workstations for High-throughput SARS-CoV-2 Testing
Scalable and modular explorer™ automated workstations maximize the efficiency of SARS-CoV-2 RT-PCR or ELISA testing.
Sensitive SARS-CoV-2 Monitoring of Wastewater
PerkinElmer’s scalable SARS-CoV-2 detection workflow combines sensitivity with the inhibition monitoring controls needed for wastewater-based epidemiology.
JANUS® G3 Workstations* for SARS-CoV-2 Testing
The recent outbreak of coronavirus (SARS-CoV-2) has highlighted the need for technologies to support rapid, high-throughput testing of biological samples.
* Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Mobile Monitoring of SARS-CoV-2 Testing
PerkinElmer has coupled the new PKeye™ Mobile Operations Monitor with the JANUS® Primary Sample reformatter and PCR liquid handler to enable your lab to increase the consistency and reliability of your automated SARS-CoV-2 detection workflow.
Saliva Workflow for SARS-CoV-2 Testing
PerkinElmer has optimized the entire workflow for SARS-CoV-2 testing of saliva samples to simplify the sample processing and increase the sensitivity of the test.
BeadBoost™ Bead Mill Homogenizer
By homogenizing saliva samples prior to processing with the BeadBoost™ Bead Mill homogenizer you can increase the sensitivity and ease of processing of SARS-CoV-2 testing from saliva samples.
Virus Research and Therapeutic Development Solutions
The COVID-19 outbreak in December 2019 resulting from the human coronavirus SARS-CoV-2 has been spreading rapidly throughout the world and has impacted the daily lives of hundreds of millions of people worldwide.
SARS-CoV-2 Workflows and Applications
Complete, Automated SARS-CoV-2 PCR Detection Workflows
NGS Solutions for Different Coronavirus Applications
NGS workflows can be used to detect SARS-CoV-2 virus, perform surveillance and epidemiological studies, track mutational changes in the virus, enable unbiased pathogen discovery, and analyze potential susceptibility and human response to SARS-CoV-2 infection.
Remote Services
Resolve instrument repairs faster and increase uptime. OneSource remote options do just that. Remote Support and Radian™ Remote Diagnostic services.
Environmental Testing in Food
Streamline surface testing of SARS-CoV-2 with an automated workflow using the PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit for Environmental Surfaces or take a simplified, direct approach by moving from sample to PCR with the DirectDetect™ SARS-CoV-2 Real-time RT-PCR kit for Environmental Surfaces
On-Demand Webinars
Origin and Evolution of the Novel SARS-Coronavirus-2Speakers Elisa Vicenzi, PhD
Maria De Lorenzis
In the last 18 years, the coronavirus disease arose at the end of 2019 is the third sever outbreak originated by a Coronavirus. What is it known as of today about SARS-CoV-2 virus? What’s the origin and how is it changing to adapt to human population? Join our webinar to learn more about the genetic discoveries of SARS-CoV-2 virus. |
An Innovative Approach to Drug Discovery and the Response to Coronavirus Disease EmergencySpeakers Lidia Pieri, PhD
Maria De Lorenzis
The folding of proteins is an interesting target for drug development that requires structural and conformational analysis of the proteins. One of the challenges in this field is the ability to predict the structure of polypeptide and full proteins. Sybilla Biotech has successfully used new algorithms implemented to the Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) drug discovery approach. Join our webinar to learn more about how this approach has been used to study the folding of ACE2 of SARS-CoV-2 virus. |
Uses of Next Generation Sequencing in SARS-CoV-2 virus Monitoring and ResearchSpeakers Market Development Manager - NGS
Maria De Lorenzis
Viruses are known to be able to change frequently their genome to be able to adapt to environmental pressure and persist in their infective action. Next generation sequencing is highly used to understand such changes and determine the origin and the evolution of the virus. Join our webinar to gain an overview of how NGS is applied in the virus study and how PerkinElmer can help in the NGS application. |
High Content Screening and Virology: A ReviewSpeakers Veronique Berchet PhD
Maria De Lorenzis
High content screening (HCS) is frequently used to study the phenotype changes of cells under different experimental conditions and to collect physiological relevant data about the cells. It is commonly used in virology research as well to understand the mechanism of action of virus when infecting cells and to screen for compounds that can inhibit such interactions. Join our webinar to learn more about how HCS can be applied in the research around SARS-CoV-2 research and how PerkinElmer can help in this field. |
News Stories
Lab Automation in a Post-COVID World
Automation has helped many labs keep pace with new and increasing demands brought on by COVID-19. In this article, our Global Director of Automated Solutions Carola Schmidt shares advice on how to setup new technology initiatives for success.
Read MoreViral Evolution Insights Will Help Us Fight COVID-19
One takeaway from COVID-19 is that understanding the mechanisms of viral evolution can help track variants in real time. Arvind Kothandaraman, our general manager of specialty diagnostics, explains how new and emerging technologies have enabled scientists and research to identify and monitor SARS-CoV-2 mutations.
Read MoreNext-Generation Sequencing for SARS-CoV-2 Surveillance
Next-generation sequencing (NGS) plays a vital role in COVID-19 surveillance. Our General Manager of NGS Michelle Fraser shares her thoughts on the latest advances in NGS technology and the global effort to track the virus and its variants.
Read MoreEuroimmun launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies
EUROIMMUN announced the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test for detecting neutralizing antibodies against SARS-CoV-2. This assay is now CE marked in over 30 countries.
Read MorePerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations
The latest RUO solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit, extends PerkinElmer’s testing portfolio to known and unknown variants.
Blog Posts
Using NGS to study the Epidemiology of 2019 Novel Coronavirus
The global COVID-19 pandemic caused by the coronavirus SARS-CoV-2 is anticipated to continue, even as countries put strict measures in place to flatten the curve in an attempt to avoid overwhelming healthcare systems. Labs are implementing high-throughput nucleic acid testing to detect viral sequences in suspected patients and are ramping up to meet the demands of population testing.
Read MorePress Releases
EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response
WALTHAM, Mass. – January 14, 2021 – PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen causing COVID-19.
Read MorePerkinElmer Launches COVID-19 Environmental Surface Testing Kits to Help Food Processors and Contract Labs Detect Presence of Virus in Facilities
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced two COVID-19 environmental testing kits to help food processors and contract labs detect the presence of SARS-CoV-2 on surfaces in food plants such as plastic, ceramic and stainless steel.
Read MorePerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection
WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 17, 2020-- PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. These modular and scalable workstations enable laboratories to ramp up SARS-CoV-2 testing capacity quickly to generate results.
Read MorePerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research
WALTHAM, Mass. -- July 22, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access PerkinElmer COVID-19 Data Dashboards to help the global scientific community accelerate the discovery of COVID-19 antivirals and vaccines.
Read MoreTechnical Content
Increase Throughput and Reduced Variability of Virus Plaque Assays with Automated Imaging and Analysis with the EnSight Application Note
Plaque Assays are a standard method utilized by virologists to determine the concentration of viruses in solution.
Read MoreProtein-Protein Interaction Approaches to Virology with HTRF Assays Application Note
Viruses rely heavily on interactions with their host to sustain their life cycle. For this reason, several steps of this cycle have long been considered desirable targets for assay development and drug discovery.
Read MoreIn Vivo Imaging of Influenza Virus Infection in Immunized Mice
Influenza is a highly infectious airborne disease with an important societal burden. Annual epidemics have occurred throughout history causing tens of millions of deaths.
Read MoreHigh-Content Analysis: Advancing Your Knowledge to Help Combat Infectious Disease
Infectious diseases remain a major burden to human health. The increased globalization of modern society that facilitates the spread of infectious diseases, and phenomena such as anti-microbial resistance, underscore the importance of the development of new preventative and therapeutic approaches.
Read MoreHigh-Throughput DNA Quantification for Next Generation Sequencing on the VICTOR Nivo Application Note
Next generation sequencing (NGS) library preparation requires accurate quantification of the genomic DNA (gDNA) starting material to begin the workflow. After library preparation, dsDNA library quantification may also be necessary prior to sequencing.
Read More